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1
INTRODUCTION
Acinetobacter Bacterium and Disease
The Acinetobacter genus is home to a wide range of bacteria that are gram-negative,
aerobic, non-motile, oxidase-negative, catalase positive, and coccobacilli with a G+C content of
39 to 47% (Bergogne-Berezin, 1996). These bacteria are universal as they reside in the soil,
water, sewage, various surfaces; and are also able to infect humans; however, a majority of the
infections are caused by the species Acinetobacter baumannii. This bacterium is the most
prevalent etiological cause of the Acinetobacter infections due to it being a nosocomial infection
or one that is acquired in a health care setting (Bergogne-Berezin, 1996). The infections that
occur in a healthcare environment are typically isolated to intensive care units and other settings
with very ill patients (Bergogne-Berezin, 1996).
Challenges Associated with Treating Acinetobacter
Acinetobacter baumannii is capable of causing several diseases within an infected
patient. These range from pneumonia to urinary tract infections. The symptoms presented vary
depending on the specific disease (Bergogne-Berezin, 1996). Because Acinetobacter baumannii
acts as a typical gram-negative, opportunistic pathogen, it infects areas such as the respiratory or
urinary tracts. It is common for patients with exposure to mechanical ventilators to suffer from
infections by Acinetobacter baumannii (Bergogne-Berezin, 1996).
These infections are difficult to treat as Acinetobacter baumannii exhibits multi-drug
resistance and, as such, is hard to control (Maragakis, 2008). These drugs include penicillins,
cephalosporins, and carbapenems. Polymyxins appear to be the most reliable drugs to use
against Acinetobacter baumannii, but there are subtypes that exhibit resistance to this class of
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drugs too (Maragakis, 2008). The high rates of antibiotic resistance in Acinetobacter species and
specifically in Acinetobacter baumannii make it difficult to treat (Bergogne-Berezin, 1996).
Next, the bacteria are able to survive for a long amount of time on surfaces and in many varying
environmental conditions. Outbreaks of this bacterial species are common because it possesses
these qualities (Maragakis, 2008).
Acinetobacter baumannii is not the only bacterial species that is difficult to treat; many
other pathogens known by the acronym ESKAPE (E. faecium, S. aureus, K. pneumoniae, A.
baumannii, P. aeruginosa, and Enterobacter species) also have high rates of antibiotic resistance.
These bacteria are pathogens that are commonly found in a healthcare setting and are resistant to
a plethora of antibiotics (Hernandez, 2015). With each being handled on a case-by-case basis, a
method to determine the subtype of the bacteria, to determine its resistance, would be very
useful.
Phage Typing
We have evidence that bacteriophages and their use would be valuable to the medical for
the identification and possible therapy of drug resistant and multi-drug resistant (MDR) bacterial
strains. The healthcare community is seeing a rise in the number of MDR bacteria in primarily
hospital settings. These bacteria cause many problems for the healthcare providers and the
patients. MDR bacteria at the very least can extend hospital stays and thereby increasing all
resources that go into that patient’s visit and at worst can cause death (de Kraker, 2011). We
believe that by using phages and phage techniques that these costs and deaths can be reduced.
We hoped that through this work we would hope to contribute to the overall knowledge of phage
and specifically to phage typing. Furthermore, we believe that with phage typing the problems
listed can be alleviated. In phage typing, collections of bacteriophages are administered to the
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bacteria isolate. The pattern in which the known phages lyse and kill the bacteria reveal the
subtype of that bacteria (Bouvet, 1989). This information would be invaluable to the healthcare
professionals, as it would allow them to choose antibiotics to which the bacteria are not resistant
(Bouvet, 1989). Bouvet et al. have also proved this method successful for Acinetobacter in the
late 1980s.
To accomplish phage typing, a set of known and characterized bacteriophages specific to
that bacterial genus must be used. The lack of bacteriophages known to infect bacterial species
is one hurdle that must be overcome to make the technique viable. A lack of up to date
information categorized in databases presents another obstacle. (Baggesen, 2010).
Phage Therapy
Another phage technique that is being explored is phage therapy. In this technique,
bacteriophages are administered to a patient with a bacterial infection with the purpose of the
bacteriophages infecting and killing the harmful bacteria in the patient. As with all phages, they
are specific to one species or subtype of a bacterial species (Baggesen, 2010). Due to this
requirement, further research into phage therapy requires known characterized phage. Our
project provides these known phages for both typing and therapy experimentation.
Currently, research is being done with phage therapy to prove its efficacy. Most
interestingly, labs have demonstrated phage therapy’s ability to improve the use of antibiotics.
Through the administration of phage, targeted bacteria are presented with evolutionary tradeoffs
that, in this study, resulted in loss of antibiotic resistance for Pseudomonas aeruginosa (Chan,
2016). Phage research is a promising field that requires large amounts of information and sets of
standardized phage to which our project can contribute.
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MATERIALS AND METHODS
Acinetobacter Culturing
Acinetobacter baylyi strains were obtained from previously existing cultures maintained
by Rose-Hulman’s lab manager Shannon Tieken. The existing cultures were t-streaked on
MacConkey agar. A single bacterial culture was picked from that plate using a flame sterilized
loop and t-streaked onto a Luria Bertani (LB) Agar plate. Furthermore, liquid cultures were
created from the bacteria grown up on that LB plate. The liquid cultures were stored in test tubes
containing 5 mL of LB broth. A single bacterial culture from the LB plate was removed using an
autoclaved toothpick that was then placed into the LB broth and allowed to grow overnight at
37ºC and shaking at 280 RPM (Mattila, 2015).
Soil Collection & Isolation of Phage
Phage was isolated from soil samples collected on Rose-Hulman’s campus. Soil was
taken from an empty patch of ground located behind the White Chapel. Approximately, 1 gram
of soil was collected and suspended in 6 mL of Luria-Bertani Broth. 300 µL of overnight grown
A. baylyi culture was then added and the solution was incubated at 37ºC for 6 hours with shaking
at 280 RPM. After the 6 hours, drops of chloroform were added to lyse bacterial cells possibly
containing phage and the solution was left to sit for 15 minutes. Following that, the solution was
subjected to vacuum filtration with 5.5cm 23 micron pore size Whatman Qualitative Filter Paper
in order to remove soil and bacterial debris. The filtrate was then taken and spun at 11,000g for
5 minutes. PEG6000 and NaCl were then added to the supernatant at final concentrations of
10% and 1M respectively. The solution was stored overnight at 4ºC and spun at 11,000g for 20
minutes the next morning. The supernatant was discarded and the surviving pellet was dissolved
in PBS. This dissolution was filtered with 0.2µm filters. The filtrate was taken and serially
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diluted 1:10. Each dilution was taken and plated for plaques using a double plaque assay (Yang,
2010; Stenholm 2008; Carey-Smith, 2006).
Double Plaque Assays
250 mL of top agar was created in addition to regular LB agar and broth in order to
perform the assay. Top agar was created from a 0.7% agar formulation of the LB agar recipe.
Bacterial phage cultures were added to 2mL exponential phase Acinetobacter baylyi and
incubated for 5 minutes. After incubation, the phage and bacteria were added to 6 mL ~45ºC
melted top agar and poured onto a dried LB agar plate. The plates were allowed to cool and then
checked after 4 hours for growth and 6 hours and overnight for plaque formation (Mocé-Llivina,
2004).
Purification of Phage
Single plaques were purified following isolation. To select one plaque a sterile Pasteur
pipette was used and a plaque was punched from the agar and placed in SM buffer. The solution
was then shook in 37ºC at 280 RPM for 2 hours. Chloroform was added to the solution at 50µL
per 1 mL of SM buffer. Phage was separated into organic layer and added to exponential phase
A. baylyi culture. This culture was then incubated for 20 minutes and used to re-perform a
double plaque assay (Stenholm, 2008).
One-Step Growth Curve
The one-step growth curves used 0.7% LB top agar and 1.5% regular recipe agar.
Exponential growth phase Acinetobacter baylyi was grown and incubated for two hours at 37ºC
and 280RPM. 10 mL of the growth phase culture was infected at an MOI of 0.01 by a prepared
culture of phage from the purification step. The solution was left to adsorb for a total of 5
minutes. After the 5 minutes, the solution was centrifuged in order to remove any excess phage.
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The supernatant was discarded and the pellets were re-suspended in 5 mL of LB broth and
incubated at 37ºC. Two sets of samples were collected every 5 minutes for 40 minutes. Each set
was immediately 10-fold serially diluted and plated for titration. The second set was treated with
chloroform to release intracellular phage. This set was then used to determine the eclipse period
of the page. From the plaque forming units on the plates, the latent and burst size of the page
were determined (Yang, 2010; Stenholm, 2008; Carey-Smith, 2006; Adams, 1959; Merabishvili,
2014).
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RESULTS
Bacteriophage that infect Acinetobacter baylyi can be found in soil surrounding RoseHulman Institute of Technology. During Dr. O’Connor’s microbiology class, students were able
to isolate Acinetobacter baylyi from soil around Rose-Hulman’s campus. Bacteriophages are
found in areas where the bacteria they infect are found, because of those factors, we
hypothesized that bacteriophages infecting Acinetobacter baylyi could be found on RoseHulman’s campus. Soil samples were collected from unfertilized ground behind the White
Chapel at the West end of campus. Following our isolation protocol, phage was acquired via
verification and culturing with double plaque assays. These assays were used throughout the rest
of the experiment for purification and amplification and were able to show that phage from
Acinetobacter baylyi can be found at Rose-Hulman (Figure 1).
Following isolation, we were able to use that isolated phage existing in the assay for
purification and amplification protocol. It is likely that the phage plaques present in the assays
obtained from isolation contained more than one strain of bacteriophage. In order to obtain one
specific strain it was necessary to perform successive rounds of plaque assays to pick and
therefore isolate one plaque of bacteriophage. This purification was carried out using lab
techniques delineated in the literature and three successive rounds of plating were achieved.
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DISCUSSION
The ESKAPE pathogens identified as targets for MDR research have been studied with
varying amounts of attention. Their threat to the future of patient care presents issues that should
be studied along with alternatives to treatment (Hernandez, 2015). We think that alternatives lie
in the use of bacteriophages for both phage typing and phage therapy. To adequately make use
of those techniques large amounts of characterized phage must be understood and that
information available. Our project focuses on those rudimentary steps necessary for the use of
those advanced techniques.
Our project was successfully able to isolate bacteriophage from soil on Rose-Hulman’s
campus and purify a single plaque with successive rounds of double plaque assays. Due to a loss
of those purified plates, characterization of the obtained plaques was not able to be accomplished
in the given time frame of the experiment. In order to fully complete the project, then several
experiments would need to be completed after reobtaining sets of purified, unknown phage.
Each of these experiments involve characterization of a set of phages that would need to be
obtained. The primary characterization technique employed would be restriction fragment length
polymorphism (RFLP). RFLP would give us both the knowledge that our obtained set of phages
are indeed different as well as a profile of those phages. Further DNA work would also be
needed (Merabishvili, 2014). Upon verification of separate phages, DNA or RNA would need to
be isolated and sent for sequencing to complete the main characterization of our phages.
Additional characterization experiments would also be needed, as phages are often
classified on several different criteria. Plaque size and type are two different physical
characteristics of the phages that are commonly used (Ackermann, 2010). Plaque size would be
measured by simply taking the diameter of the acquired plaques, and plaque type of lytic or
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lysogenic can be recorded through simple observation of the plaques themselves (Urban-Chmiel,
2015; Merabishvili, 2014). Lastly, activity of the phages would be characterized using a onestep growth curve. That assay would quantify the infective activity of the phages with their host
bacterium (Yang, 2010; Stenholm, 2008; Carey-Smith, 2006; Adams, 1959; Merabishvili, 2014).
In the future, phages may have several applications ranging from typing to therapy. With
a database of characterized phage made available, then phage typing methods could be used in
the future in order to identify the subtypes of bacterial strains and help physicians to choose
treatment options based on those phage profiles. Additionally, phage therapy has been gaining
attention as a possible treatment option to use with antibiotic treatment. Phage therapy has the
added benefit of a historical basis for its use dating back to World War I and extensive use in
former Soviet Bloc states (Levine, 1992). Current research shows that phage therapy could be a
viable treatment option to use with antibiotics to increase their effectiveness and further research
may reveal that standalone phage treatments are a viable option for certain infections (Chan,
2016).
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CONCLUSION
Our project focused on the discovery and identification of bacteriophage that infected
Acinetobacter baylyi. We succeeded in isolating and purifying those phages from soil samples
taken on the campus of Rose-Hulman Institute of Technology. Our project shows that phages
infecting these bacteria may be found in the soil in which they inhabit and if their prevalence in
the environment matches that Acinetobacter baylyi, then a great diversity of phage may be
present. Phage research has the potential for many applications including phage typing and
therapy. To make those applications viable, a great deal of collected and characterized phage
need to be studied. This project aimed to contribute to that collection. It provides a base for
future research at Rose-Hulman with the existing methods and strategies employed in this
project.
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FIGURES
Figure 1: Double plaque assay containing initial purification. Bacterial phage cultures were
added to 2mL exponential phase Acinetobacter baylyi and incubated for 5 minutes. These phage
were taken from soil from around Rose-Hulman’s campus and isolated using vacuum filtration
with 5.5cm 23 micron pore size Whatman Qualitative Filter Paper in order to remove soil and
bacterial debris. That filtrate was spun into a pellet. These pellets were then dissolved in PBS
and subjected to a 0.2 micron filter. This phage solution was then serially diluted and incubated.
After incubation, the phage and bacteria were added to 6 mL ~45ºC melted top agar and poured
onto a dried LB agar plate. The plates were allowed to cool and then checked after 4 hours for
growth and 6 hours and overnight for plaque formation. Plaque formation indicates the presence
of phage that infects Acinetobacter baylyi from the isolation protocol.

